ASTM F2884-21
(Guide)Standard Guide for Pre-clinical in vivo Evaluation of Spinal Fusion
Standard Guide for Pre-clinical <emph type="bdit">in vivo</emph> Evaluation of Spinal Fusion
SIGNIFICANCE AND USE
4.1 This guide is aimed at providing a range of in vivo models to aid in pre-clinical research and development of tissue-engineered medical products (TEMPs) intended for the clinical repair or regeneration of bone in the spine.
4.2 This guide includes a description of the animal models, surgical considerations, and tissue processing as well as the qualitative and quantitative analysis of tissue specimens.
4.3 The user is encouraged to utilize appropriate ASTM and other guidelines to conduct cytotoxicity and biocompatibility tests on materials, TEMPs, or both, prior to assessment of the in vivo models described herein.
4.4 It is recommended that safety testing be in accordance with the provisions of the FDA Good Laboratory Practices Regulations 21 CFR 58.
4.5 Safety and effectiveness studies to support regulatory submissions (for example, Investigational Device Exemption (IDE), Premarket Approval (PMA), 510K, Investigational New Drug (IND), or Biologics License Application (BLA) submissions in the U.S.) should conform to appropriate guidelines of the regulatory bodies for development of medical devices, biologics, or drugs.
4.6 Animal model outcomes are not necessarily predictive of human results and should, therefore, be interpreted cautiously with respect to potential applicability to human conditions.
SCOPE
1.1 This guide covers general guidelines for the pre-clinical in vivo assessment of tissue-engineered medical products (TEMPs) intended to repair or regenerate bone in an interbody and/or posterolateral spinal environment. TEMPs included in this guide may be composed of, but are not limited to, natural or synthetic biomaterials or composites thereof, and may contain cells or biologically active agents such as growth factors, synthetic peptides, plasmids, or cDNA. The models described in this document represent a stringent test of a material’s ability to induce and/or augment bone growth in the spinal environment.
1.2 While clinically TEMPs may be combined with hardware for initial stabilization or other purposes, the focus of this guide is on the appropriateness of the animal model chosen and evaluation of the TEMP-induced repair and as such does not focus on issues of components or constructs.
1.3 Guidelines include a description and rationale of various animal models for the in vivo assessment of the TEMP. The animal models utilize a range of species including rat (murine), rabbit (lapine), dog (canine), goat (caprine), pig (porcine), sheep (ovine), and non-human primate (primates). Outcome measures include in vivo assessments based on radiographic, histologic, and CT imaging as well as subsequent in vitro assessments of the repair, including histologic analyses and mechanical testing. All methods are described briefly and referenced. The user should refer to specific test methods for additional detail.
1.4 This guide is not intended to include the testing of raw materials, preparation of biomaterials, sterilization, or packaging of the product. ASTM standards for these steps are available in Referenced Documents (Section 2).
1.5 The use of any of the methods included in this guide may not produce a result that is consistent with clinical performance in one or more specific applications.
1.6 Other pre-clinical methods may also be appropriate, and this guide is not meant to exclude such methods. The material must be suitable for its intended purpose. Additional biological testing in this regard would be required.
1.7 The values stated in SI units are to be regarded as standard. No other units of measurement are included in this standard.
1.8 The values stated in inch-pound units are to be regarded as standard. The values given in parentheses are mathematical conversions to SI units that are provided for information only and are not considered standard.
1.9 This international standard was developed in accordance with internationally recognized prin...
General Information
Standards Content (Sample)
This international standard was developed in accordance with internationally recognized principles on standardization established in the Decision on Principles for the
Development of International Standards, Guides and Recommendations issued by the World Trade Organization Technical Barriers to Trade (TBT) Committee.
Designation: F2884 − 21
Standard Guide for
1
Pre-clinical in vivo Evaluation of Spinal Fusion
This standard is issued under the fixed designation F2884; the number immediately following the designation indicates the year of
original adoption or, in the case of revision, the year of last revision. A number in parentheses indicates the year of last reapproval. A
superscript epsilon (´) indicates an editorial change since the last revision or reapproval.
1. Scope 1.6 Other pre-clinical methods may also be appropriate, and
this guide is not meant to exclude such methods. The material
1.1 This guide covers general guidelines for the pre-clinical
must be suitable for its intended purpose.Additional biological
in vivo assessment of tissue-engineered medical products
testing in this regard would be required.
(TEMPs) intended to repair or regenerate bone in an interbody
1.7 The values stated in SI units are to be regarded as
and/or posterolateral spinal environment. TEMPs included in
standard. No other units of measurement are included in this
this guide may be composed of, but are not limited to, natural
or synthetic biomaterials or composites thereof, and may standard.
contain cells or biologically active agents such as growth
1.8 The values stated in inch-pound units are to be regarded
factors, synthetic peptides, plasmids, or cDNA. The models
as standard. The values given in parentheses are mathematical
described in this document represent a stringent test of a
conversions to SI units that are provided for information only
material’s ability to induce and/or augment bone growth in the
and are not considered standard.
spinal environment.
1.9 This international standard was developed in accor-
1.2 While clinically TEMPs may be combined with hard-
dance with internationally recognized principles on standard-
ware for initial stabilization or other purposes, the focus of this
ization established in the Decision on Principles for the
guideisontheappropriatenessoftheanimalmodelchosenand
Development of International Standards, Guides and Recom-
evaluation of the TEMP-induced repair and as such does not
mendations issued by the World Trade Organization Technical
focus on issues of components or constructs.
Barriers to Trade (TBT) Committee.
1.3 Guidelinesincludeadescriptionandrationaleofvarious
2. Referenced Documents
animal models for the in vivo assessment of the TEMP. The
2
2.1 ASTM Standards:
animalmodelsutilizearangeofspeciesincludingrat(murine),
F561 Practice for Retrieval and Analysis of Medical
rabbit (lapine), dog (canine), goat (caprine), pig (porcine),
Devices, and Associated Tissues and Fluids
sheep (ovine), and non-human primate (primates). Outcome
F565 PracticeforCareandHandlingofOrthopedicImplants
measures include in vivo assessments based on radiographic,
and Instruments
histologic, and CT imaging as well as subsequent in vitro
F895 TestMethodforAgarDiffusionCellCultureScreening
assessments of the repair, including histologic analyses and
for Cytotoxicity
mechanical testing. All methods are described briefly and
F981 Practice for Assessment of Compatibility of Biomate-
referenced. The user should refer to specific test methods for
rials for Surgical Implants with Respect to Effect of
additional detail.
Materials on Muscle and Insertion into Bone
1.4 This guide is not intended to include the testing of raw
F1983 Practice forAssessment of Selected Tissue Effects of
materials, preparation of biomaterials, sterilization, or packag-
Absorbable Biomaterials for Implant Applications
ing of the product. ASTM standards for these steps are
F2150 Guide for Characterization and Testing of Biomate-
available in Referenced Documents (Section 2).
rial Scaffolds Used in Regenerative Medicine and Tissue-
1.5 The use of any of the methods included in this guide Engineered Medical Products
may not produce a result that is consistent with clinical 2.2 Other Standards:
performance in one or more specific applications. ISO 10993 Biological Evaluation of Medical TEMPs—Part
3
5: Tests for in vitro Cytotoxicity
1 2
This guide is under the jurisdiction of ASTM Committee F04 on Medical and For referenced ASTM standards, visit the ASTM website, www.astm.org, or
Surgical Materials and Devices and is the direct responsibility of Subcommittee contact ASTM Customer Service at service@astm.org. For Annual Book of ASTM
F04.44 on Assessment for TEMPs. Standards volume information, refer to the standard’s Document Summary page on
Current edition approved Dec. 15, 2021. Published January 2022. Originally the ASTM website.
3
approvedin2012.Lastpreviouseditionapprovedin2012asF2884 – 12,whichwas Available fromAmerican National Standa
...
Questions, Comments and Discussion
Ask us and Technical Secretary will try to provide an answer. You can facilitate discussion about the standard in here.